Chemotherapy-induced peripheral neurotoxicity in immune-deficient mice: New useful ready-to-use animal models
暂无分享,去创建一个
[1] M. Berciano,et al. Reactive nucleolar and Cajal body responses to proteasome inhibition in sensory ganglion neurons. , 2014, Biochimica et biophysica acta.
[2] David L. Bennett,et al. Evaluation of tubulin polymerization and chronic inhibition of proteasome as citotoxicity mechanisms in bortezomib-induced peripheral neuropathy , 2014, Cell cycle.
[3] Maree T. Smith,et al. Pathobiology of cancer chemotherapy-induced peripheral neuropathy (CIPN) , 2013, Front. Pharmacol..
[4] M. Pisanu,et al. Monitoring response to cytostatic cisplatin in a HER2(+) ovary cancer model by MRI and in vitro and in vivo MR spectroscopy , 2013, British Journal of Cancer.
[5] Y. H. Han,et al. Dexamethasone inhibits the effect of paclitaxel on human ovarian carcinoma xenografts in nude mice. , 2013, European review for medical and pharmacological sciences.
[6] G. Cavaletti,et al. Bortezomib-Induced Painful Peripheral Neuropathy: An Electrophysiological, Behavioral, Morphological and Mechanistic Study in the Mouse , 2013, PloS one.
[7] C. Segebarth,et al. Synergistic effect of cisplatin and synchrotron irradiation on F98 gliomas growing in nude mice , 2013, Journal of synchrotron radiation.
[8] M. Goetz,et al. Matrix detachment and proteasomal inhibitors diminish Sulf-2 expression in breast cancer cell lines and mouse xenografts , 2013, Clinical & Experimental Metastasis.
[9] Lin Mei,et al. Paclitaxel drug delivery systems , 2013, Expert opinion on drug delivery.
[10] S. Warmann,et al. Effect of sorafenib combined with cytostatic agents on hepatoblastoma cell lines and xenografts , 2012, British Journal of Cancer.
[11] B. Giometto,et al. Treatment for paraneoplastic neuropathies. , 2012, The Cochrane database of systematic reviews.
[12] Jianmin Yang,et al. Bortezomib suppresses the growth of leukemia cells with Notch1 overexpression in vivo and in vitro , 2012, Cancer Chemotherapy and Pharmacology.
[13] Guido Cavaletti,et al. Chemotherapy-induced peripheral neurotoxicity (CIPN): an update. , 2012, Critical reviews in oncology/hematology.
[14] G. Cavaletti,et al. Comparison of neuropathy-inducing effects of eribulin mesylate, paclitaxel, and ixabepilone in mice. , 2011, Cancer research.
[15] G. Cavaletti,et al. Multimodal assessment of painful peripheral neuropathy induced by chronic oxaliplatin-based chemotherapy in mice , 2011, Molecular pain.
[16] G. Cavaletti,et al. Neurophysiological and neuropathological characterization of new murine models of chemotherapy-induced chronic peripheral neuropathies , 2010, Experimental Neurology.
[17] G. Cavaletti,et al. The role of oxidative stress and anti-oxidant treatment in platinum-induced peripheral neurotoxicity. , 2010, Current cancer drug targets.
[18] G. Cavaletti,et al. Glutamate Carboxypeptidase Inhibition Reduces the Severity of Chemotherapy-Induced Peripheral Neurotoxicity in Rat , 2010, Neurotoxicity Research.
[19] G. Cavaletti,et al. Bortezomib‐induced painful neuropathy in rats: A behavioral, neurophysiological and pathological study in rats , 2010, European journal of pain.
[20] B. Aggarwal,et al. Curcumin circumvents chemoresistance in vitro and potentiates the effect of thalidomide and bortezomib against human multiple myeloma in nude mice model , 2009, Molecular Cancer Therapeutics.
[21] M. Fujita,et al. Mechanical allodynia induced by paclitaxel, oxaliplatin and vincristine: different effectiveness of gabapentin and different expression of voltage-dependent calcium channel alpha(2)delta-1 subunit. , 2009, Biological & pharmaceutical bulletin.
[22] M. Friedlander,et al. Mechanisms underlying chemotherapy-induced neurotoxicity and the potential for neuroprotective strategies. , 2008, Current medicinal chemistry.
[23] P. Dougherty,et al. Behavioral and electrophysiological studies in rats with cisplatin-induced chemoneuropathy , 2008, Brain Research.
[24] A. Argyriou,et al. Bortezomib-induced peripheral neuropathy in multiple myeloma: a comprehensive review of the literature. , 2008, Blood.
[25] P. Dougherty,et al. Quantitative sensory findings in patients with bortezomib-induced pain. , 2007, The journal of pain : official journal of the American Pain Society.
[26] P. Ghezzi,et al. Cisplatin-induced peripheral neuropathy: neuroprotection by erythropoietin without affecting tumour growth. , 2007, European journal of cancer.
[27] Misaki Matsumoto,et al. Inhibition of Paclitaxel-Induced A-Fiber Hypersensitization by Gabapentin , 2006, Journal of Pharmacology and Experimental Therapeutics.
[28] N. Munshi,et al. Emerging trends in the clinical use of bortezomib in multiple myeloma. , 2005, Clinical lymphoma & myeloma.
[29] G. Nicolini,et al. Morphological and morphometric analysis of paclitaxel and docetaxel-induced peripheral neuropathy in rats. , 2005, European journal of cancer.
[30] A. Fagan,et al. A proteasomal stress response: pre‐treatment with proteasome inhibitors increases proteasome activity and reduces neuronal vulnerability to oxidative injury , 2004, Journal of neurochemistry.
[31] T. Hickish,et al. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. , 2004, The New England journal of medicine.
[32] T. Libermann,et al. Molecular sequelae of proteasome inhibition in human multiple myeloma cells , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[33] Huifang Huang,et al. Solution Structure of a Cisplatin-Induced DNA Interstrand Cross-Link , 1995, Science.
[34] G. Cavaletti,et al. Experimental Peripheral Neuropathy Induced in Adult Rats by Repeated Intraperitoneal Administration of Taxol , 1995, Experimental Neurology.
[35] Roy E. Furman,et al. Cisplatin neuropathy. Risk factors, prognosis, and protection by WR‐2721 , 1988, Cancer.
[36] A. Kato,et al. Effects of the prostaglandin E1 analog limaprost on mechanical allodynia caused by chemotherapeutic agents in mice. , 2009, Journal of pharmacological sciences.
[37] I. Barajon,et al. Morphometric study of the sensory neuron and peripheral nerve changes induced by chronic cisplatin (DDP) administration in rats , 2004, Acta Neuropathologica.
[38] G. Cavaletti,et al. Experimental cisplatin neuronopathy in rats and the effect of retinoic acid administration , 2004, Journal of Neuro-Oncology.
[39] G. Cavaletti,et al. Effect on the peripheral nervous system of the short-term intravenous administration of paclitaxel in the rat. , 1997, Neurotoxicology.
[40] S. Horwitz,et al. Mechanism of action of taxol. , 1992, Trends in pharmacological sciences.